- Home
- FCBC vs CSTL Comparison
FCBC vs CSTL Comparison
Compare FCBC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCBC
- CSTL
- Stock Information
- Founded
- FCBC 1874
- CSTL 2007
- Country
- FCBC United States
- CSTL United States
- Employees
- FCBC N/A
- CSTL N/A
- Industry
- FCBC Major Banks
- CSTL Medical Specialities
- Sector
- FCBC Finance
- CSTL Health Care
- Exchange
- FCBC Nasdaq
- CSTL Nasdaq
- Market Cap
- FCBC 696.3M
- CSTL 661.7M
- IPO Year
- FCBC 1992
- CSTL 2019
- Fundamental
- Price
- FCBC $32.22
- CSTL $23.74
- Analyst Decision
- FCBC
- CSTL Strong Buy
- Analyst Count
- FCBC 0
- CSTL 6
- Target Price
- FCBC N/A
- CSTL $37.67
- AVG Volume (30 Days)
- FCBC 39.5K
- CSTL 256.3K
- Earning Date
- FCBC 10-28-2025
- CSTL 11-03-2025
- Dividend Yield
- FCBC 3.72%
- CSTL N/A
- EPS Growth
- FCBC N/A
- CSTL N/A
- EPS
- FCBC 2.68
- CSTL N/A
- Revenue
- FCBC $164,262,000.00
- CSTL $346,269,000.00
- Revenue This Year
- FCBC $2.27
- CSTL N/A
- Revenue Next Year
- FCBC $11.13
- CSTL N/A
- P/E Ratio
- FCBC $12.02
- CSTL N/A
- Revenue Growth
- FCBC 0.67
- CSTL 20.40
- 52 Week Low
- FCBC $31.75
- CSTL $14.59
- 52 Week High
- FCBC $49.02
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- FCBC 37.39
- CSTL 54.78
- Support Level
- FCBC $32.37
- CSTL $23.31
- Resistance Level
- FCBC $34.10
- CSTL $24.86
- Average True Range (ATR)
- FCBC 0.95
- CSTL 0.86
- MACD
- FCBC 0.09
- CSTL 0.08
- Stochastic Oscillator
- FCBC 20.22
- CSTL 59.42
About FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.